These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7668330)

  • 1. Pathogenesis of brain dysfunction in Batten disease.
    Walkley SU; March PA; Schroeder CE; Wurzelmann S; Jolly RD
    Am J Med Genet; 1995 Jun; 57(2):196-203. PubMed ID: 7668330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue culture loading test with storage granules from animal models of neuronal ceroid-lipofuscinosis (Batten disease): testing their lysosomal degradability by normal and Batten cells.
    Elleder M; Drahota Z; Lisá V; Mares V; Mandys V; Müller J; Palmer DN
    Am J Med Genet; 1995 Jun; 57(2):213-21. PubMed ID: 7668332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease.
    March PA; Wurzelmann S; Walkley SU
    Am J Med Genet; 1995 Jun; 57(2):204-12. PubMed ID: 7668331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
    Kopra O; Vesa J; von Schantz C; Manninen T; Minye H; Fabritius AL; Rapola J; van Diggelen OP; Saarela J; Jalanko A; Peltonen L
    Hum Mol Genet; 2004 Dec; 13(23):2893-906. PubMed ID: 15459177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution of lesions in Batten disease.
    Chronister R; Dyken P; Fields PA; Maertens P
    Am J Med Genet; 1995 Jun; 57(2):191-5. PubMed ID: 7668329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease).
    Palmer DN; Fearnley IM; Walker JE; Hall NA; Lake BD; Wolfe LS; Haltia M; Martinus RD; Jolly RD
    Am J Med Genet; 1992 Feb; 42(4):561-7. PubMed ID: 1535179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model: ceroidosis (ceroid-lipofuscinosis) in Australian cattle dogs.
    Wood PA; Sisk DB; Styer E; Baker HJ
    Am J Med Genet; 1987 Apr; 26(4):891-8. PubMed ID: 3591832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6).
    Oswald MJ; Palmer DN; Kay GW; Shemilt SJ; Rezaie P; Cooper JD
    Neurobiol Dis; 2005 Oct; 20(1):49-63. PubMed ID: 16137566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A form of juvenile Batten disease with granular osmiophilic deposits.
    Lake BD; Brett EM; Boyd SG
    Neuropediatrics; 1996 Oct; 27(5):265-9. PubMed ID: 8971748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
    Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
    Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview.
    Jolly RD
    Am J Med Genet; 1995 Jun; 57(2):307-11. PubMed ID: 7668352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sheep and other animals with ceroid-lipofuscinoses: their relevance to Batten disease.
    Jolly RD; Martinus RD; Palmer DN
    Am J Med Genet; 1992 Feb; 42(4):609-14. PubMed ID: 1535180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathologic features of ceroid lipofuscinosis in two Australian cattle dogs.
    Sisk DB; Levesque DC; Wood PA; Styer EL
    J Am Vet Med Assoc; 1990 Aug; 197(3):361-4. PubMed ID: 2391273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-specific pathology in neurons cultured from sheep affected with ceroid lipofuscinosis.
    Hughes SM; Kay GW; Jordan TW; Rickards GK; Palmer DN
    Mol Genet Metab; 1999 Apr; 66(4):381-6. PubMed ID: 10191133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal ceroid lipofuscinoses: the same, but different?
    Cooper JD
    Biochem Soc Trans; 2010 Dec; 38(6):1448-52. PubMed ID: 21118105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease).
    Jolly RD; Brown S; Das AM; Walkley SU
    Neurochem Int; 2002 May; 40(6):565-71. PubMed ID: 11850114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical studies in the ceroid-lipofuscinoses (Batten disease) using antibodies to subunit c of mitochondrial ATP synthase.
    Westlake VJ; Jolly RD; Bayliss SL; Palmer DN
    Am J Med Genet; 1995 Jun; 57(2):177-81. PubMed ID: 7668326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.